Joseph H. Antin, MD

Publications

• Melanson SE, Stevenson K, Kim H, Antin JH, Court MH, Ho VT, Ritz J, Soiffer RJ, Kuo FC, Longtine JA, Jarolim P.Response to helsby and tingle.Am J Hematol. 2011 Apr;86(4):384.
  21442648
• Sarantopoulos S, Stevenson KE, Kim HT, Washel WS, Bhuiya NS, Cutler CS, Alyea EP, Ho VT, Soiffer RJ, Antin JH, Ritz J.Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.Blood. 2011 Feb 17;117(7):2275-83.
  21097674
• Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH.Optimization of therapy for severe aplastic anemia based on clinic
  21034841
• Ho VT, Kim HT, Aldridge J, Liney D, Kao G, Armand P, Koreth J, Cutler C, Ritz J, Antin JH, Soiffer RJ, Alyea EP.Use of Matched Unrelated Donors Compared with Matched Related Donors Is Associated with Lower Relapse and Superior Progression-Free Survival af
  21193054
• Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR.Seroprotective Titers against 2009-H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantatio
  20950701
• Melanson SE, Stevenson K, Kim H, Antin JH, Court MH, Ho VT, Ritz J, Soiffer RJ, Kuo FC, Longtine JA, Jarolim P.Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell tran
  21108329
• Cutler C, Antin JH.Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update.Curr Opin Hematol. 2010 Nov;17(6):500-4.
  20717025
• Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K.NCI First International Workshop on the Biology, Prevention, and Treatment of
  20699125
• Koreth J, Biernacki M, Aldridge J, Kim HT, Alyea EP, Armand P, Cutler C, Ho VT, Wu CJ, Antin JH, Soiffer RJ.Syngeneic Donor Hematopoietic Stem Cell Transplantation is Associated with High Rates of Engraftment Syndrome.Biol Blood Marrow Transplant. 2010 Se
  20870027
• Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, Koreth J, Alyea EP, Hearsey D, Neufeld EJ, Fleming MD, Steen H, Anderson D, Kwong RY, Soiffer RJ, Antin JH.Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Tra
  20854920
• Cutler C, Stevenson K, Kim HT, Brown J, McDonough S, Herrera M, Reynolds C, Liney D, Kao G, Ho V, Armand P, Koreth J, Alyea E, Dey BR, Attar E, Spitzer T, Boussiotis VA, Ritz J, Soiffer R, Antin JH, Ballen K.Double umbilical cord blood transplantation wit
  20697368
• Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, M
  20167278
• Ballen KK, Cutler C, Yeap BY, McAfee SL, Dey BR, Attar EC, Chen YB, Haspel RL, Liney D, Koreth J, Ho V, Alyea EP, Soiffer RJ, Spitzer TR, Antin JH.Donor Derived Second Hematologic Malignancies after Cord Blood Transplantation.Biol Blood Marrow Transplant.
  20178854
• Marks DI, Wang T, Pérez WS, Antin JH, Copelan E, Gale RP, George B, Gupta V, Halter J, Khoury HJ, Klumpp TR, Lazarus HM, Lewis VA, McCarthy P, Rizzieri DA, Sabloff M, Szer J, Tallman MS, Weisdorf D.The outcome of full intensity and reduced intensity cond
  20404137
• Antin JH.The 2010 Education Supplement on Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant. 2010 Jan 1;16(1):S1.
  20640174
• Cutler C, Kim HT, Ayanian S, Bradwin G, Revta C, Aldridge J, Ho V, Alyea E, Koreth J, Armand P, Soiffer R, Ritz J, Richardson PG, Antin JH.Prediction Of Veno-Occlusive Disease Using Biomarkers Of Endothelial Injury.Biol Blood Marrow Transplant. 2010 Aug;1
  20184961
• Brown JA, Stevenson K, Kim HT, Cutler C, Ballen K, McDonough S, Reynolds C, Herrera M, Liney D, Ho V, Kao G, Armand P, Koreth J, Alyea E, McAfee S, Attar E, Dey B, Spitzer T, Soiffer R, Ritz J, Antin JH, Boussiotis VA.Clearance of CMV viremia and survival
  20107229
• Koreth J, Aldridge J, Kim HT, Alyea EP, Cutler C, Armand P, Ritz J, Antin JH, Soiffer RJ, Ho VT.Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced
  20074656
• Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, Cutler C, Ho VT, Alyea EP, Antin JH, Soiffer RJ, Ritz J.Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
  20389017
• Koreth J, Antin JH.Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation.Haematologica. 2010 Mar;95(3):364-6.
  20207843
• Ofran Y, Kim HT, Brusic V, Blake L, Mandrell M, Wu CJ, Sarantopoulos S, Bellucci R, Keskin DB, Soiffer RJ, Antin JH, Ritz J.Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
  20160060
• Chang G, Meadows ME, Jones JA, Antin JH, Orav EJ.Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS).Am J Drug Alcohol Abuse. 2010 Jan;36(1):1-6.
  20141389
• Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, Guinan E, Vogelsang G, Krishnan A, Giralt S, Revta C, Carreau NA, Iacobelli M, Carreras E, Ruutu T, Barbui T, Antin JH, Niederwieser D.Hepatic veno-occlusive disease following stem cell t
  19766729
• Storb R, Antin JH, Cutler C.Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?.Biol Blood Marrow Transplant. 2010 Jan;16(1 Suppl):S18-27. Review.
  19857584
• McCarroll SA, Bradner JE, Turpeinen H, Volin L, Martin PJ, Chilewski SD, Antin JH, Lee SJ, Ruutu T, Storer B, Warren EH, Zhang B, Zhao LP, Ginsburg D, Soiffer RJ, Partanen J, Hansen JA, Ritz J, Palotie A, Altshuler D.Donor-recipient mismatch for common ge
  19935662
• Koreth J, Stevenson KE, Kim HT, Garcia M, Ho VT, Armand P, Cutler C, Ritz J, Antin JH, Soiffer RJ, Alyea EP.Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell tra
  19713456
• Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn JY, Cervantes F, Copelan E, Gale R, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Arora M, .Sibling versus unrelated donor
  19822308
• Ho VT, Vanneman M, Kim H, Sasada T, Kang YJ, Pasek M, Cutler C, Koreth J, Alyea E, Sarantopoulos S, Antin JH, Ritz J, Canning C, Kutok J, Mihm MC, Dranoff G, Soiffer R.Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines ea
  19717467
• Korngold R, Antin JH.Biology and management of acute graft-versus-host disease.Cancer Treat Res. 2009;144:257-75. Review.
  19779886
• Chang G, Meadows ME, Orav EJ, Antin JH.Mental status changes after hematopoietic stem cell transplantation.Cancer. 2009 Oct 1;115(19):4625-35.
  19551887
• Chen YB, Kim HT, McDonough S, Odze RD, Yao X, Lazo-Kallanian S, Spitzer TR, Soiffer R, Antin JH, Ritz J.Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease follow
  19660719
• Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S, .Prior rituximab correlates with less acute graft-versus-ho
  19344418
• Ho VT, Aldridge J, Kim HT, Cutler C, Koreth J, Armand P, Antin JH, Soiffer RJ, Alyea EP.Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after
  19539216
• Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H, Appelbaum FR, Döhner H, Antin JH, Soiffer RJ, Cutler C.Allogeneic stem cell transplantation for acute myeloid leukemia in first complete re
  19509382
• Arora M,Weisdorf DJ,Spellman SR,Haagenson MD,Klein JP,Hurley CK,Selby GB,Antin JH,Kernan NA,Kollman C,Nademanee A,McGlave P,Horowitz MM,Petersdorf EW.HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for
  19224849
• Oliansky DM,Antin JH,Bennett JM,Deeg HJ,Engelhardt C,Heptinstall KV,de Lima M,Gore SD,Potts RG,Silverman LR,Jones RB,McCarthy PL Jr,Hahn T.The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndrom
  19167676
• Sarantopoulos S,Stevenson KE,Kim HT,Cutler CS,Bhuiya NS,Schowalter M,Ho VT,Alyea EP,Koreth J,Blazar BR,Soiffer RJ,Antin JH,Ritz J.Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.Blood. 2009 Apr 16;113(16):3865-74.
  19168788
• Delaney M,Cutler CS,Haspel RL,Yeap BY,McAfee SL,Dey BR,Attar E,Kao G,Alyea EP,Koreth J,Ho VT,Saidman S,Liney D,Sese D,Soiffer RJ,Spitzer TR,Antin JH,Ballen KK.High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in
  19159415
• Ringden O,Pavletic SZ,Anasetti C,Barrett AJ,Wang T,Wang D,Antin JH,Di Bartolomeo P,Bolwell BJ,Bredeson C,Cairo MS,Gale RP,Gupta V,Hahn T,Hale GA,Halter J,Jagasia M,Litzow MR,Locatelli F,Marks DI,McCarthy PL,Cowan MJ,Petersdorf EW,Russell JA,Schiller GJ,Sc
  19059878
• Armand P,Gannamaneni S,Kim HT,Cutler CS,Ho VT,Koreth J,Alyea EP,LaCasce AS,Jacobsen ED,Fisher DC,Brown JR,Canellos GP,Freedman AS,Soiffer RJ,Antin JH.Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis afte
  19001324
• Cutler C,Stevenson K,Kim HT,Richardson P,Ho VT,Linden E,Revta C,Ebert R,Warren D,Choi S,Koreth J,Armand P,Alyea E,Carter S,Horowitz M,Antin JH,Soiffer R.Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem c
  18776081
• Lee SJ,Kukreja M,Wang T,Giralt SA,Szer J,Arora M,Woolfrey AE,Cervantes F,Champlin RE,Gale RP,Halter J,Keating A,Marks DI,McCarthy PL,Olavarria E,Stadtmauer EA,Abecasis M,Gupta V,Khoury HJ,George B,Hale GA,Liesveld JL,Rizzieri DA,Antin JH,Bolwell BJ,Caraba
  18664621
• Yanik GA,Ho VT,Levine JE,White ES,Braun T,Antin JH,Whitfield J,Custer J,Jones D,Ferrara JL,Cooke KR.The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell
  18664626
• Alyea EP,Li S,Kim HT,Cutler C,Ho V,Soiffer RJ,Antin JH.Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplant
  18640576
• Armistead PM,Mohseni M,Gerwin R,Walsh EC,Iravani M,Chahardouli B,Rostami S,Zhang W,Neuberg D,Rioux J,Ghavamzadeh A,Ritz J,Antin JH,Wu CJ.Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic ste
  18550258
• Haspel RL, Kao G, Yeap BY, Cutler C, Soiffer RJ, Alyea EP, Ho VT, Koreth J, Dey BR, McAfee SL, Attar EC, Spitzer T, Antin JH, Ballen KK.Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantatio
  18037942
• Armand P, Kim HT, Ho VT, Cutler CS, Koreth J, Antin JH, LaCasce AS, Jacobsen ED, Fisher DC, Brown JR, Canellos GP, Freedman AS, Soiffer RJ, Alyea EP.Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: impor
  18342784
• Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ.Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.Biol Blood Marrow Transplant. 2008 Feb;14(2):197-207.
  18215780
• Schlenk RF, Pasquini MC, Perez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Buchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Dohner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierr
  18215779
• Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Ritz J, Alyea EP, Antin JH, Soiffer RJ.A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2008 Jan;14
  18158958
• Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB.Clinical evaluation of oral chronic graft-versus-host disease.Biol Blood Marrow Transplant. 2008 Jan;14(1):110-5.
  18158967
• Ferrara JL, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, Levine J, Schultz K, Appelbaum F, Negrin R, Giralt S, Bredeson C, Heslop H, Horowitz M.Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.Biol Blood Marr
  17950914
• Sarantopoulos S, Stevenson KE, Kim HT, Bhuiya NS, Cutler CS, Soiffer RJ, Antin JH, Ritz J.High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Clin Cancer Res. 2007 Oct 15;13(20):6107-14.
  17947475
• Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, Baden LR, Bromfield EB.Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.Neurology. 2007 Jul 10;69(2):156-65.
  17620548
• Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, Antin JH, Baden LR.Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoieti
  17392502
• Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, Dey BR, Attar E, McAfee S, Konopleva M, Antin JH, Spitzer TR.Phase I trial of parathyroid hormone to facilitate stem cell mobilization.Biol Blood Marrow Transplant. 2007 Jul;13(7):838-43.
  17580262
• Saito AM, Zahrieh D, Cutler C, Ho VT, Antin JH, Soiffer RJ, Alyea EP, Lee SJ.Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy.Bone Marrow Transplant. 2007 Aug;40(3):2
  17563734
• Armand P, Kim HT, Deangelo DJ, Ho VT, Cutler CS, Stone RM, Ritz J, Alyea EP, Antin JH, Soiffer RJ.Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation.Biol Blood Marrow Transplant. 2007 Jun;13(6):65
  17531775
• Armand P, Antin JH.Allogeneic stem cell transplantation for aplastic anemia.Biol Blood Marrow Transplant. 2007 May;13(5):505-16. Review.
  17448909
• Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH.Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.Blood. 2007 May 15;109(10):4586-8.
  17234738
• Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, Haspel R, Kao G, Liney D, Alyea E, Lee S, Cutler C, Ho V, Soiffer R, Antin JH.Double unrelated reduced-intensity umbilical cord blood transplantation in adults.Biol Blood Marrow Transplant. 2007 J
  17222756
• Cutler C, Li S, Ho VT, Koreth J, Alyea E, Soiffer RJ, Antin JH.Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.Blood. 2007 Apr 1;109(7):3108
  17138818
• Brown JR, Kim HT, Li S, Stephans K, Fisher DC, Cutler C, Ho V, Lee SJ, Milford EL, Ritz J, Antin JH, Soiffer RJ, Gribben JG, Alyea EP.Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced
  17084369
• Alyea EP, Kim HT, Ho V, Cutler C, DeAngelo DJ, Stone R, Ritz J, Antin JH, Soiffer RJ.Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
  17067911
• Porter DL, Antin JH.Donor leukocyte infusions in myeloid malignancies: new strategies.Best Pract Res Clin Haematol. 2006;19(4):737-55. Review.
  16997180
• Humphreys BD, Vanguri VK, Henderson J, Antin JH.Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient.Nat Clin Pract Nephrol. 2006 Sep;2(9):535-9; quiz 540.
  16941046
• Lee SJ, Kim HT, Ho VT, Cutler C, Alyea EP, Soiffer RJ, Antin JH.Quality of life associated with acute and chronic graft-versus-host disease.Bone Marrow Transplant. 2006 Aug;38(4):305-10.
  16819438
• Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH.Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2006 May;12(5):552-9.
  16635790
• Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D, Klickstein LB, Levin J, Miller K, Reynolds C, Macdonell R, Pasek M, Lee SJ, Ho V, Soiffer R, Antin JH, Ritz J, Alyea E.Rituximab for steroid-refractory chronic graft-versus-host disease.Blood. 20
  16551963
• Ho VT, Kim HT, Liney D, Milford E, Gribben J, Cutler C, Lee SJ, Antin JH, Soiffer RJ, Alyea EP.HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.Bone Marrow Transplant. 2006
  16532020
• Cutler C, Antin JH.Chronic graft-versus-host disease.Curr Opin Oncol. 2006 Mar;18(2):126-31. Review.
  16462180
• Wu CJ, Krishnamurti L, Kutok JL, Biernacki M, Rogers S, Zhang W, Antin JH, Ritz J.Evidence for ineffective erythropoiesis in severe sickle cell disease.Blood. 2005 Nov 15;106(10):3639-45.
  16091448
• Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E, Ho V, Lee SJ, Soiffer R, Antin JH.Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2005 Jul;11(7):551-7.
  15983555
• Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Bellucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J.Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.Blood. 2005 Oct 15;106(8):2903-11.
  15972448
• Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G, , ,.Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de
  15878974
• Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L, Harrison MJ, Ho V, Alyea E, Lee SJ, Soiffer R, Sonis S, Antin JH.Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containi
  15846292
• Antin JH, Guinan EC, Avigan D, Soiffer RJ, Joyce RM, Martin VJ, Molrine DC.Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2005 Mar;11(3):213-22.
  15744240
• Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC, Antin JH, Myerson D, Hamilton SR, Vogelstein B, Kinzler KW, Lengauer C.Contribution of bone marrow-derived endothelial cells to human tumor vasculature.Nat Med. 2005 Mar;11(3):261-2.
  15723071
• Alyea EP, Kim HT, Ho VT, Cutler C, Gribben J, DeAngelo DJ, Lee SJ, Windawi S, Ritz J, Stone RM, Antin JH, Soiffer RJ.Comparative outcome of non-myeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients greater than fifty y
  15459007
• Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, Hochberg EP, Wu CJ, Alyea EP, Cutler C, Ho V, Soiffer RJ, Antin JH, Ritz J.Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remiss
  15613541
• Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ.Routine screening for psychosocial distress following hematopoietic stem cell transplantation.Bone Marrow Trans
  15502851
• Oh H, Loberiza FR Jr, Zhang MJ, Ringden O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neud
  15486071
• Cutler C, Antin JH.Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.Bone Marrow Transplant. 2004 Sep;34(6):471-6. Review.
  15273708
• Lee SJ, Zahrieh D, Agura E, MacMillan ML, Maziarz RT, McCarthy PL, Ho VT, Cutler C, Alyea EP, Antin JH, Soiffer RJ.Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-vs.-host disease: results of a randomized trial.B
  15138163
• DeAngelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, Galinsky I, Parekkedon B, Ritz J, Antin JH, Stone RM, Soiffer RJ.Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic trans
  15297408
• Ho VT, Zahrieh D, Hochberg E, Micale E, Levin J, Reynolds C, Steckel S, Cutler C, Fisher DC, Lee SJ, Alyea EP, Ritz J, Soiffer RJ, Antin JH.Safety and Efficacy of Denileukin Diftitox in Patients with Steroid Refractory Acute Graft-versus-Host Disease afte
  15113758
• Cutler C, Kim HT, Hochberg E, Ho V, Alyea E, Lee SJ, Fisher DC, Miklos D, Levin J, Sonis S, Soiffer RJ, Antin JH.Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell
  15111932
• Zorn E, Miklos DB, Floyd BH, Mattes-Ritz A, Guo L, Soiffer RJ, Antin JH, Ritz J.Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation.J Exp Med. 2004 Apr 19;199(8):1133-42.
  15096539
• Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM.A decision analysis of a
  15039286
• Zubair AC, Zahrieh D, Daley H, Schott D, Gribben JG, Alyea EP, Schlossman R, Freedman A, Antin JH, Soiffer RJ, Neuberg D, Ritz J.Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.Transfusion. 2004 Feb;44(2):253-61.
  14962317
• Spiryda LB, Laufer MR, Soiffer RJ, Antin JA.Graft-versus-host disease of the vulva and/or vagina: Diagnosis and treatment.Biol Blood Marrow Transplant. 2003 Dec;9(12):760-5.
  14677115
• Antin JH.Stem cell transplantation-harnessing of graft-versus-malignancy.Curr Opin Hematol. 2003 Nov;10(6):440-4.
  14564175
• Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A, Viatte S, Soiffer RJ, Antin JH, Ritz J.Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.Blood. 2004 J
  14512314
• Milinkovic M, Antin JH, Hergrueter CA, Underhill CB, Sackstein R.CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.Blood. 2004 Jan 15;103(2):740-2.
  14504094
• Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, Baden LR.Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplan
  12855583
• Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC.Optimistic expectations and survival after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2003 Jun;9(6):389-96.
  12813447
• Wadleigh M, Richardson PG, Zahrieh D, Lee SJ, Cutler C, Ho V, Alyea EP, Antin JH, Stone RM, Soiffer RJ, DeAngelo DJ.Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allog
  12738663
• Antin JH, Kim HT, Cutler C, Ho VT, Lee SJ, Miklos DB, Hochberg EP, Wu CJ, Alyea EP, Soiffer RJ.Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.Blood.
  12730113
• Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB.Performance of a new clinical grading system for chronic graft-versus-host disease: a multi
  12714524
• Zubair A, Zahrieh D, Daley H, Schott D, Gribben JG, Freedman A, Ritz J.Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution.Transfusion. 2003 May;43(5):614-21.
  12702183
• Alyea EP, Weller E, Fisher DC, Freedman AS, Gribben JG, Lee S, Schlossman RL, Stone RM, Friedberg J, DeAngelo D, Liney D, Windawi S, Ng A, Mauch P, Antin JH, Soiffer RJ.Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogenei
  12463479
• Soiffer RJ, Alyea EP, Hochberg E, Wu C, Canning C, Parikh B, Zahrieh D, Webb I, Antin J, Ritz J.Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.Biol Blood Marrow Transplant
  12463482
• DiNubile MJ, Stossel TP, Ljunghusen OC, Ferrara JL, Antin JH.Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.Blood. 2002 Dec 15;100(13):4367-71.
  12393536
• Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R, Malinoski F, Trocciola S, Wilson M, Ambrosino DM.Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell tra
  12393732
• Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC.Multi-institutional use of de
  12393437
• Antin JH, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, Lee SJ, Alyea E, McGarigle C, Blazar BR, Sonis S, Soiffer RJ, Ferrara JL.Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-contr
  12393661
• Hochberg EP, Miklos DB, Neuberg D, Eichner DA, McLaughlin SF, Mattes-Ritz A, Alyea EP, Antin JH, Soiffer RJ, Ritz J.A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transp
  12393452
• Lee SJ, Zahrieh D, Alyea EP, Weller E, Ho VT, Antin JH, Soiffer RJ.Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.Blood. 2002 Oct 15;100(8):2697
  12351374
• Lee S, Cook EF, Soiffer R, Antin JH.Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.Biol Blood Marrow Transplant. 2002;8(8):444-52.
  12234170
• Lin TS, Zahrieh D, Weller E, Alyea EP, Antin JH, Soiffer RJ.Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.Transplantation. 2002 Jul 15;74(1):49-54.
  12134098
• Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM.Severity of chronic graft-versus-host disease: association with treatment-related mor
  12091329
• Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ.Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.J Clin Oncol. 2002 Apr 15;20(8):2118-26.
  11956273
• Antin JH, Lee SJ, Neuberg D, Alyea E, Soiffer RJ, Sonis S, Ferrara JL.A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.Bone Marrow Trans
  11919725
• Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM.The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transpl
  11719355
• Antin JH, Childs R, Filipovich AH, Giralt S, Mackinnon S, Spitzer T, Weisdorf D.Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the In
  11669214
• Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL.Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated d
  11567988
• Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.A multicenter, randomized, double-blind comparison of differe
  11509937
• Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH.Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.J Clin Oncol. 2001 Aug 15;19(16):3685-91.
  11504750
• Wheeler C, Khurshid A, Ibrahim J, Elias A, Mauch P, Ault K, Antin J.Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation foll
  11426523
• Antin JH.Acute graft-versus-host disease: inflammation run amok?.J Clin Invest. 2001 Jun;107(12):1497-8.
  11413153
• Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ.Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2001;7(4):223-9.
  11349809
• Porter DL, Luger SM, Duffy KM, Stadtmauer EA, Laport G, Schuster SJ, Orloff G, Tsai D, McDaid K, Kathakali A, Leonard DG, Antin JH.Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.Biol Blood Marrow Transplant. 20
  11349810
• Cutler C, Antin JH.Peripheral blood stem cells for allogeneic transplantation: a review.Stem Cells. 2001;19(2):108-17.
  11239165
• Lee SJ, Fairclough D, Antin JH, Weeks JC.Discrepancies between patient and physician estimates for the success of stem cell transplantation.JAMA. 2001 Feb 28;285(8):1034-8.
  11209174
• Soiffer RJ, Weller E, Alyea EP, Mauch P, Webb IL, Fisher DC, Freedman AS, Schlossman RL, Gribben J, Lee S, Anderson KC, Marcus K, Stone RM, Antin JH, Ritz J.CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in pa
  11181681
• Schiffer CA, Miller K, Larson RA, Amrein PC, Antin JH, Zani VJ, Stone RM.A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients
  10753831
• Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, Antin JH, Weeks JC.Recovery after stem-cell transplantation for hematologic diseases.J Clin Oncol. 2001 Jan 1;19(1):242-52.
  11134219
• Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT, Nademanee A, Noreen H, King R, Confer D, Kernan NA.Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.Blood. 2000 D
  11110679
• Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, Przepiorka D, Davies S, Petersen FB, Bartels P, Buell D, Fitzsimmons W, Anasetti C, Storb R, Ratanatharathorn V.Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclospor
  10979948
• Lee SJ, Klar N, Weeks JC, Antin JH.Predicting costs of stem-cell transplantation.J Clin Oncol. 2000 Jan;18(1):64-71.
  10623694
• Porter DL, Collins RH, Shpilberg O, Drobyski WR, Connors JM, Sproles A, Antin JH.Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.Biol Blood Marrow Transplant. 1999;5(4):253-61.
  10465105
• Sehn LH, Alyea EP, Weller E, Canning C, Lee S, Ritz J, Antin JH, Soiffer RJ.Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.J Clin
  10080600
• Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH.ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.Transfusion. 1999 Feb;39(2):179-87.
  10037129
• Benjamin RJ, Connors JM, McGurk S, Churchill WH, Antin JH.Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.Biol Blood Marrow Transplant. 1998;4(3):151-6.
  9923413
• Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC.The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.Blood. 1998 Dec 1;92(11):4047-52.
  9834208
• Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM, Molrine DC.Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.Bone Marrow Transplant.
  9827969
• Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmon
  9746768
• Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, Kinchla NM, Neuberg D, Waller EK, Antin JH, Soiffer R, Vredenburgh J, Lill M, Woolfrey AE, Bearman SI, Iacobelli M, Fareed J, Guinan EC.Treatment of severe veno-occlusive disease with
  9680339
• Chang G, McGarigle C, Spitzer TR, McAfee SL, Harris F, Piercy K, Goetz MN, Antin JH.A comparison of related and unrelated marrow donors.Psychosom Med. 1998 Mar-Apr;60(2):163-7.
  9560864
• Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler C.Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.Blood. 1998 Jan 15;91(2):717-23.
  9427731
• Ziegler TR, Bye RL, Persinger RL, Young LS, Antin JH, Wilmore DW.Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study.Am J Med Sci. 1998 Jan;315(1):4-10.
  9427568
• Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ, Ferrara JL, Bierer BE, Weinstein HJ, Antin JH.Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.Bone Marrow Transplant. 1997 Nov;20(9):
  9384475
• Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH.Guillain-Barré syndrome following allogeneic bone marrow transplantation.Neurology. 1997 Dec;49(6):1711-4.
  9409375
• Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH.Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.Ann Intern Med. 1997
  9412310
• Chan CY, Molrine DC, Antin JH, Wheeler C, Guinan EC, Weinstein HJ, Phillips NR, McGarigle C, Harvey S, Schnipper C, Ambrosino DM.Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral bloo
  9232253
• Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH.Treatment of chronic graft-versus-host disease with clofazimine.Blood. 1997 Apr 1;89(7):2298-302.
  9116272
• Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J.Donor leukocyte infusions in 140 patients with relapsed malignancy after allog
  9053463
• Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH.Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.Bone Marrow Transplant. 1996 Nov;1
  8932854